FENNEC PHARMACEUTICALS INC. (FENC) Return on equity 2016–2025
FENNEC PHARMACEUTICALS INC. (FENC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-27.5%FY2025 · since FY2016: -78.1% → -27.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -27.5% | — |
| FY2020 | -62.3% | +45.3 pp |
| FY2019 | -107.6% | -61.2 pp |
| FY2018 | -46.4% | -20.1 pp |
| FY2017 | -26.3% | +51.8 pp |
| FY2016 | -78.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More FENC financial trends
FENC RevenueFENC Net incomeFENC Net marginFENC Gross profitFENC Gross marginFENC Operating incomeFENC Operating marginFENC Operating cash flowFENC Free cash flowFENC Capital expendituresFENC Stock buybacksFENC Dividends paidFENC Total assetsFENC Total liabilitiesFENC Shareholders’ equityFENC overview →